ABSI earnings date and last-quarter result: last quarter beat, P/E -9.93. Updated 2026-07-23.
Absci (ABSI) Research Hub
Absci (ABSI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 9.45 USD (+2.94%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.93, market cap 1.40B. This hub links to the full technical, earnings and options research available for ABSI.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.45 USD (+2.94%) |
| 52-week range | 6.69 USD – 12 USD |
| Trend regime | Range |
| 14-day RSI | 44.6 (Bearish) |
| Trailing P/E | -9.93 |
| Market cap | 1.40B |
| Dividend yield | 0.00% |
Available research for ABSI
Covered Call on ABSI: how it works, illustrative setup around the real 9.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABSI: how it works, illustrative setup around the real 9.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABSI: how it works, illustrative setup around the real 9.45 USD price, max profit/loss, breakeven and when to use it. Educational.
ABSI technical analysis: range, last 9.45 USD, RSI 44.6, 52w range 6.69 USD–12 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ABSI in?
Absci (ABSI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABSI in an uptrend or downtrend?
As of 2026-10-26, ABSI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABSI's trailing P/E ratio?
ABSI's trailing P/E is -9.93, with a market cap of 1.40B. See the earnings research page for full valuation detail.